Theseus Pharmaceuticals Inc. (THRX) Fundamentals

Theseus Pharmaceuticals Inc is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. The company's development programs are designed to address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer.
SHARE INFORMATION
Market Cap$ 322,870,006
Shares Outstanding38,713,430
Float15,602,400
Percent Float40.3%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -2.89
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions119
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months766,255
Institutional Holdings Percent111.2%
Institutional Sold Previous 3 Months1,211,159
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months165,000
Insider Holdings Percent4.9
Insider Sold Previous 3 Months-
Insider Shares Owned1,904,421
TRADING INFO
52 Week High$ 24.54
52 Week Low$ 4.86
52 Week High Change$ 0.00
21 Day Moving Average$ 7.5605
21 Day Extended Moving Average$ 7.6407
50 Day Moving Average$ 6.6666
50 Day Extended Moving Average$ 7.3769
200 Day Moving Average$ 10.2659
200 Day Extended Moving Average$ 10.1112
10 Day Average Volume35,583
20 Day Average Volume42,392
30 Day Average Volume58,575
50 Day Average Volume102,892
Alpha-0.046334
Beta2.5581
Standard Deviation0.204660
R20.568449
7 Day Price Change$ -0.34
7 Day Percent Change-3.92%
21 Day Price Change$ 1.52
21 Day Percent Change22.29%
30 Day Price Change$ 1.47
30 Day Percent Change21.4%
Month to Date Price Change$ 1.13
Month to Date Percent Change15.67%
Quarter to Date Price Change$ 2.81
Quarter to Date Percent Change50.81%
180 Day Price Change$ -4.56
180 Day Percent Change-35.35%
200 Day Price Change$ -0.65
200 Day Percent Change-7.23%
Year to Date Price Change$ -4.34
Year to Date Percent Change-34.23%

Theseus Pharmaceuticals Inc. (THRX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.40
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio43.70
Leverage Ratio1.30
Quick Ratio43.10
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-2.60
Enterprise Value$ 92,999,783
Price to Sales0.00
Price to Free Cash-10.00
PE High Last 5 Years0.00
Price To Book1.40
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-22.43
Return on Equity-41.29
Return on Capital-39.48

Theseus Pharmaceuticals Inc. (THRX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOTimothy P. Clackson
Emplyoees26
Last AuditUQ
CIK0001745020
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address245 Main Street
Cambridge, MA 2142
Websitehttps://www.theseusrx.com
Facsimile-
Telephone+1 857 400-9491
Email-


Your Recent History
NASDAQ
THRX
Theseus Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.